[F-18]Florastamin

DRUG2 trials

Sponsors

FutureChem

Conditions

High Risk Prostate Carcinoma

Phase 3

Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis

Active, not recruitingNCT05004285

FutureChemHigh Risk Prostate Carcinoma

Start: 2021-04-28End: 2025-06-01Target: 398Updated: 2025-03-12

[18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer

Active, not recruitingNCT05936658

FutureChemHigh Risk Prostate Carcinoma

Start: 2023-05-08End: 2025-06-30Updated: 2025-03-12